Pilot initiative for rare diseases to lay the foundation for the adoption of precision health across Canada.

Genomics-based precision health promises to improve patient health and increase efficiency of health-care delivery. Today, Genome Canada launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step.

Patients with rare diseases could get significant improvement in the results of their health care by precision health approaches due to their unique genetic makeup and diagnosis challenges. This program promises every rare disease patient in Canada the opportunity for a diagnosis and hope for treatment.

By establishing shared and effective policies, processes, techniques and technologies, it will also form the first step towards a national roll-out of precision health for all Canadians.


For further information, read Genome Canada’s press release.